Lyell Immunopharma (LYEL) Asset Utilization Ratio (2021 - 2026)
Lyell Immunopharma's (LYEL) Asset Utilization Ratio came in at 0.00 for Q2 2026, down 44.6% from 0.00 a year earlier and down 9.1% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Since Q3 2021, Lyell Immunopharma has reported Asset Utilization Ratio for 20 quarters.
- Annual Asset Utilization Ratio has declined for three consecutive years.
- In prior years, Lyell Immunopharma's Asset Utilization Ratio was 0.00 in FY2024 (-36.2%), 0.00 in FY2023 (-99.8%), 0.08 in FY2022 (+683.9%) and 0.01 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Asset Utilization Ratio since Q2 2024.
- On a year-over-year basis, Asset Utilization Ratio has declined in each of the last three quarters, with an average decline of 11.2% over the last eight quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q4 2022, with growth of 865.8%; the weakest was Q1 2024, with a decline of 99.9%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.00 (Q1 2026), 0.00 (Q4 2025) and 0.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Lyell Immunopharma | 225.31 Mn | 225.31 Mn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
API Access
Lyell Immunopharma Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();